Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth, Vascular | 6 | 2018 | 241 | 0.810 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2016 | 140 | 0.680 |
Why?
|
| Muscle, Smooth | 4 | 2009 | 354 | 0.570 |
Why?
|
| Cell Differentiation | 5 | 2016 | 1521 | 0.530 |
Why?
|
| Embryonic Stem Cells | 2 | 2012 | 80 | 0.510 |
Why?
|
| Proto-Oncogene Proteins c-myb | 3 | 2018 | 9 | 0.400 |
Why?
|
| Coronary Vessels | 1 | 2012 | 190 | 0.380 |
Why?
|
| Adenocarcinoma | 3 | 2008 | 1194 | 0.270 |
Why?
|
| Muscle Proteins | 3 | 2011 | 133 | 0.240 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2009 | 395 | 0.230 |
Why?
|
| Cysts | 1 | 2014 | 106 | 0.220 |
Why?
|
| Carcinoma, Papillary | 1 | 2014 | 159 | 0.210 |
Why?
|
| Peptides | 3 | 2016 | 646 | 0.210 |
Why?
|
| Prostatic Neoplasms | 3 | 2008 | 1768 | 0.200 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 556 | 0.190 |
Why?
|
| Mucous Membrane | 2 | 2009 | 83 | 0.190 |
Why?
|
| Urothelium | 2 | 2009 | 71 | 0.180 |
Why?
|
| Image Cytometry | 2 | 2007 | 12 | 0.180 |
Why?
|
| Trans-Activators | 2 | 2016 | 443 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 2 | 2011 | 228 | 0.170 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 413 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 435 | 0.170 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 291 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 6 | 2018 | 956 | 0.160 |
Why?
|
| Nuclear Proteins | 2 | 2016 | 726 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 635 | 0.150 |
Why?
|
| Myosin-Light-Chain Kinase | 3 | 2011 | 41 | 0.150 |
Why?
|
| Actins | 3 | 2012 | 458 | 0.150 |
Why?
|
| Aneuploidy | 1 | 2007 | 57 | 0.150 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2009 | 170 | 0.140 |
Why?
|
| Antibodies | 1 | 2009 | 353 | 0.140 |
Why?
|
| Adventitia | 1 | 2016 | 1 | 0.140 |
Why?
|
| Ataxin-1 | 1 | 2016 | 3 | 0.140 |
Why?
|
| Ploidies | 1 | 2006 | 41 | 0.140 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 22 | 0.140 |
Why?
|
| Venoms | 1 | 2016 | 12 | 0.140 |
Why?
|
| Neoplasm Staging | 2 | 2009 | 2001 | 0.140 |
Why?
|
| Platelet Aggregation | 1 | 2016 | 44 | 0.130 |
Why?
|
| Pathology, Clinical | 1 | 2006 | 34 | 0.130 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2016 | 35 | 0.130 |
Why?
|
| Logistic Models | 2 | 2007 | 1212 | 0.130 |
Why?
|
| Binding Sites | 4 | 2018 | 1117 | 0.130 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2012 | 57 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2880 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2015 | 14 | 0.130 |
Why?
|
| Urinary Bladder | 1 | 2007 | 246 | 0.130 |
Why?
|
| Statistics as Topic | 1 | 2006 | 234 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 2 | 2012 | 142 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2015 | 58 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 143 | 0.120 |
Why?
|
| Mice | 7 | 2018 | 11737 | 0.120 |
Why?
|
| Observer Variation | 1 | 2006 | 610 | 0.120 |
Why?
|
| Carcinoma | 1 | 2007 | 443 | 0.120 |
Why?
|
| Stem Cells | 1 | 2016 | 372 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2018 | 551 | 0.110 |
Why?
|
| Culture Media, Serum-Free | 1 | 2012 | 21 | 0.110 |
Why?
|
| Thrombosis | 1 | 2016 | 302 | 0.110 |
Why?
|
| Vasoconstriction | 1 | 2012 | 92 | 0.100 |
Why?
|
| Biopsy | 1 | 2006 | 1182 | 0.100 |
Why?
|
| Mice, SCID | 1 | 2012 | 261 | 0.100 |
Why?
|
| Animals | 10 | 2018 | 27317 | 0.100 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 19 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 421 | 0.090 |
Why?
|
| Transcriptome | 1 | 2015 | 628 | 0.090 |
Why?
|
| Peptide Fragments | 3 | 2011 | 463 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1650 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2011 | 0.090 |
Why?
|
| Serum Response Factor | 2 | 2009 | 45 | 0.080 |
Why?
|
| Muscle Development | 1 | 2009 | 41 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 76 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 313 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2009 | 84 | 0.080 |
Why?
|
| Calcium | 1 | 2012 | 1172 | 0.080 |
Why?
|
| Skin | 1 | 2011 | 581 | 0.080 |
Why?
|
| Biopsy, Needle | 2 | 2008 | 233 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 557 | 0.070 |
Why?
|
| Humans | 14 | 2016 | 89063 | 0.070 |
Why?
|
| Transfection | 3 | 2016 | 911 | 0.070 |
Why?
|
| DNA, Neoplasm | 2 | 2007 | 268 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2015 | 1652 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2016 | 89 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2018 | 136 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2005 | 146 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2008 | 599 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 217 | 0.060 |
Why?
|
| Myosin Heavy Chains | 1 | 2005 | 91 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2016 | 89 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 212 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2016 | 638 | 0.050 |
Why?
|
| Male | 6 | 2015 | 42251 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 1975 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 1867 | 0.040 |
Why?
|
| RNA Interference | 2 | 2011 | 376 | 0.040 |
Why?
|
| Antagomirs | 1 | 2018 | 4 | 0.040 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2018 | 8 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2009 | 130 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 3209 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2018 | 94 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2007 | 67 | 0.040 |
Why?
|
| Point Mutation | 1 | 2018 | 245 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2007 | 152 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2008 | 590 | 0.040 |
Why?
|
| Societies, Scientific | 1 | 2007 | 43 | 0.040 |
Why?
|
| World Health Organization | 1 | 2007 | 106 | 0.040 |
Why?
|
| Photometry | 1 | 2006 | 14 | 0.040 |
Why?
|
| Cytogenetic Analysis | 1 | 2006 | 71 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 2016 | 28 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2016 | 22 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2016 | 45 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 16 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2015 | 27 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2015 | 44 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 576 | 0.030 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2015 | 36 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 71 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 77 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2006 | 478 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2007 | 359 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 69 | 0.030 |
Why?
|
| Time Factors | 2 | 2016 | 5320 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 125 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 64 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1796 | 0.030 |
Why?
|
| Pancreas | 1 | 2016 | 244 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2007 | 575 | 0.030 |
Why?
|
| ROC Curve | 1 | 2006 | 781 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 340 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 1990 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1715 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 1574 | 0.030 |
Why?
|
| Leupeptins | 1 | 2011 | 22 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2011 | 12 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2011 | 15 | 0.030 |
Why?
|
| K562 Cells | 1 | 2011 | 44 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2011 | 53 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 25863 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 6288 | 0.020 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2011 | 16 | 0.020 |
Why?
|
| Activins | 1 | 2011 | 26 | 0.020 |
Why?
|
| Troponin | 1 | 2011 | 24 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2011 | 52 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 71 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 85 | 0.020 |
Why?
|
| Adult | 2 | 2014 | 26507 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2011 | 106 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 198 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 1157 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 1848 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2495 | 0.020 |
Why?
|
| Tretinoin | 1 | 2011 | 128 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 275 | 0.020 |
Why?
|
| Aged | 2 | 2008 | 19077 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2007 | 2863 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 252 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 1043 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 276 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 1239 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2007 | 2290 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 691 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 2439 | 0.020 |
Why?
|
| Lung | 1 | 2016 | 1258 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2362 | 0.020 |
Why?
|
| Mutation | 2 | 2011 | 4132 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 1237 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 661 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 740 | 0.020 |
Why?
|
| AT Rich Sequence | 1 | 2006 | 7 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 6777 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 3373 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 1487 | 0.020 |
Why?
|
| Biomarkers | 1 | 2011 | 1755 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 4040 | 0.020 |
Why?
|
| Female | 1 | 2014 | 46011 | 0.010 |
Why?
|